Paula A Price
CIK 1369240 · Chief Financial Officer · last filed 2026-10-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ACN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
ROUTE 206 AND PROVINCE LINE ROAD
PRINCETON, NJ 08543
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WBD | Director | 0 | $30.95 | $0 | $0 | 12 | 2026-10-06 |
| ACN | Director | 8,561 | $240.26 | $2.06M | -$985.7K | 68 | 2026-08-17 |
| MDLZ | Director | 9,662 | $62.74 | $606.2K | $0 | 3 | 2026-05-21 |
| BMY | Director | — | $61.12 | — | $0 | 13 | 2026-02-03 |
| DVA | Director | 1,395 | $176.81 | $246.6K | -$184.4K | 9 | 2022-05-17 |
| WDC | Director | 7,545 | $378.51 | $2.86M | -$503.2K | 29 | 2022-02-01 |
| M | Chief Financial Officer | 2,010 | $23.43 | $47.1K | $25.3K | 3 | 2019-07-10 |
| DG | Director | 6,472 | $132.12 | $855.1K | $20.0K | 10 | 2018-05-31 |
| CHRS | Director | 0 | $1.02 | $0 | $0 | 3 | 2012-06-15 |
| CVS | Controller | 16,498 | $93.45 | $1.54M | $0 | 4 | 2008-02-14 |
Recent Filings · Page 5 of 16
155 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-02-17 | ACN | Mixed | +3 | -$570 | EDGAR |
| 2023-02-03 | BMY | Grant (A) | — | $0 | EDGAR |
| 2023-02-02 | ACN | Grant (A) | +855 | $0 | EDGAR |
| 2023-01-30 | ACN | Tax (F) | −239 | -$65.5K | EDGAR |
| 2022-12-21 | ACN | Mixed | −944 | -$194.1K | EDGAR |
| 2022-11-17 | ACN | Grant (A) | +5 | $0 | EDGAR |
| 2022-08-17 | ACN | Grant (A) | +4 | $0 | EDGAR |
| 2022-06-30 | WBD | Grant (A) | +16,106 | $0 | EDGAR |
| 2022-05-17 | ACN | Grant (A) | +4 | $0 | EDGAR |
| 2022-05-17 | DVA | Grant (A) | +475 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.